Estrella Immunopharma's total assets for Q were $8.63M, a decrease of -8.61% from the previous quarter. ESLA total liabilities were $138.49K for the fiscal quarter, a -65.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.